Zymeworks(ZYME) - 2025 Q3 - Quarterly Results

Zymeworks Provides Corporate Update and Reports Third Quarter 2025 Financial Results Vancouver, British Columbia (November 6, 2025) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today reported financial results for the three and nine months ended September 30, 2025 and provided a summary of r ...